Aducanumab FDA Approval for Alzheimer's Disease: The Importance of G…

Anton Porsteinsson

Differentiating Early Signs of Alzheimer Disease From Normal Signs o…

ACHL

J. Galvin

Lewy Body Dementia: The Most Common Disease You Never Heard Of

University of Miami

J. Galvin

AAIC 2024 Insights: Reducing the Effects of Aging on Cognition With …

AAIC 2024 Insights Hub

C. Camargo

Cognitive Disorders

ZINCARE

M. Mataa

Gut Microbiome and the Brain

BRAIN PONDERINGS podcast with Mark Mattson

J. Cryan

AAIC 2024 Insights: Potential of Targeting the Alpha-1 Adrenergic Re…

AAIC 2024 Insights Hub

S. G. Pattanashetty

Early Diagnosis of Alzheimer’s Disease

Sharon Cohen

Updates in Dementia

2023 Conference Coverage

P. Tipton

AAIC 2024 Insights: Developing an AI Algorithm to Detect Predictors …

AAIC 2024 Insights Hub

J. Butler

AAIC 2024 Insights: qEEG as Biomarker for Alzheimer's Disease - Inve…

AAIC 2024 Insights Hub

C. Simfukwe

Alzheimer's: Clinical Pearls

Lawrence Robbins

Lewy Body Dementia: The Most Common Disease You Never Heard Of - 2024

AdventHealth

J. Galvin

The Illusion of Progress: Lecanemab in Alzheimer's Disease

Alberto Espay

Frontotemporal Dementias and Selective Neuronal Vulnerability

BRAIN PONDERINGS podcast with Mark Mattson

W. Seeley, M. Mattson

AAIC 2024 Insights: Plasma Aβ42/Aβ40 and Phospho-Tau217 Concentratio…

AAIC 2024 Insights Hub

R. Rissman

Imaging for Dementia with Clinical Cases

APP2APP Virtual Lectures, Inc

S. Best

A New Era for Brain Health in Primary Care: New Drugs and Diagnostics

University of Kansas Medical Center

J. M. Burns

An Update on Alzheimer's Disease: New Strategies Across the Disease …

Miller Medical Communications

P. Tariot

AAIC 2024 Insights: Subclinical Atherosclerosis and Brain Health in …

AAIC 2024 Insights Hub

C. Tristão Pereira